300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Digital Media
FinTech
Art
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Real Estate
Non Profit
Sporting Goods
Internet
Android
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Seychelles
Moldova
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
El Salvador
Rwanda
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Bangladesh
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Finland
Algeria
Belize
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Italy
Mongolia
Belarus
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Asia (August 2026)

The most active venture capital funds and angel investors investing in Asia Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Prox Ventures
VC Fund
10 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$28M
Qiming Venture Partners
VC Fund
6 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$134M
Mitsubishi UFJ Capital
VC Fund
6 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $1.2M–$198M
SMBC Venture Capital
VC Fund
6 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $1.5M–$184M
Linear Capital
VC Fund
6 China, Singapore, Switzerland Seed, Angel, Series A Artificial Intelligence, Software, Manufacturing $1.4M–$122M
IT-Farm
VC Fund
6 United States, Japan, Germany Seed, Series A Software, Health Care, Medical $1.5M–$16M
Hillhouse Investment
VC Fund
6 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
5 Japan, United States, India Seed, Series A, Series B Health Care, Biotechnology, Medical $2.5M–$100M
HSG
VC Fund
5 China, United States, Australia Series B, Series A, Seed Artificial Intelligence, Biotechnology, Software $2M–$282M
Hillhouse Ventures
VC Fund
5 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care $10M–$120M
DG Daiwa Ventures
VC Fund
5 Japan, United States, India Seed, Series A, Series B Software, FinTech, Artificial Intelligence $679k–$122M
Lenovo Capital and Incubator Group (LCIG)
VC Fund
5 China, Hong Kong, United States Series A, Seed, Series B Manufacturing, Artificial Intelligence, Software $1.5M–$150M
SBI Investment
VC Fund
5 Japan, South Korea, United States Series B, Series A Software, Information Technology, Financial Services $2.3M–$142M
Osaka University Venture Capital
VC Fund
4 Japan Seed, Series A Biotechnology, Health Care, Medical $1.8M–$49M
Dalton Venture
VC Fund
4 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $450k–$50M
EFung Capital
VC Fund
4 China, United States, India Series B, Series A, Series C Health Care, Biotechnology, Medical $1.4M–$100M
Vinno Capital
VC Fund
4 China, United States Series A, Series B, Seed Manufacturing, Semiconductor, Medical $1.4M–$139M
Nissay Capital
VC Fund
4 Japan, United States, Ethiopia Seed, Series A Health Care, Information Technology, Medical $565k–$71M
Huagai Capital
VC Fund
4 China, United States, Hong Kong Series A, Series B, Angel Health Care, Biotechnology, Medical $425k–$147M
Baidu Ventures
VC Fund
4 China, United States, Singapore Series A, Seed, Series B Artificial Intelligence, Health Care, Biotechnology $1.4M–$145M
Miyako Capital
VC Fund
4 Japan, United States, United Kingdom Series A, Seed, Series B Medical, Biotechnology, Information Technology $750k–$354M
UntroD Capital
VC Fund
4 Japan, Singapore, Austria Seed, Series A Manufacturing, Biotechnology, Health Care $772k–$90M
JAFCO
VC Fund
3 Japan, United States, Israel Series A, Series B Information Technology, Software, Artificial Intelligence $2.1M–$184M
CITIC Capital Holdings
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $2.8M–$230M
Longpan Investment
VC Fund
3 China, United States, Cayman Islands Series A, Series B, Seed Health Care, Medical, Biotechnology $14M–$60M
BioVenture
VC Fund
3 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $3.8M–$73M
ULTIMA
VC Fund
3 China Angel, Series A, Series B Health Care, Biotechnology, Fitness $1.6M–$15M
Keio Innovation Initiative
VC Fund
3 Japan, United Kingdom Series A, Seed Health Care, Medical, Biotechnology $826k–$64M
Entrepreneurship Relay Group
VC Fund
3 China Series A, Angel Manufacturing, Software, Enterprise $222k–$30M
ANRI
VC Fund
3 Japan, United States, Indonesia Seed, Series A Software, Medical, Health Care $413k–$41M
Legend Capital
VC Fund
3 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.9M–$200M
Haitang Fund
VC Fund
3 China Series A, Seed, Venture - Series Unknown Manufacturing, Biotechnology, Medical $1.5M–$103M
WuXi AppTec
VC Fund
3 United States, China, Israel Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6M–$187M
Japan Science and Technology Agency
VC Fund
3 Japan Series A, Seed Biotechnology, Medical, Manufacturing $1.7M–$255M
Shenzhen Capital Group
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Software $1.6M–$156M
ZSVC
VC Fund
3 China, United States, India Series A, Seed, Series B Manufacturing, Medical, Health Care $1.4M–$85M
Northern Light Venture Capital
VC Fund
3 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $1.3M–$100M
Mizuho Capital
VC Fund
3 Japan, United States, Singapore Series A, Series B Information Technology, Software, Artificial Intelligence $2M–$269M
MiraclePlus
VC Fund
3 China, United States, Singapore Seed, Angel, Pre-Seed Artificial Intelligence, Software, Information Technology
Inspiration Capital
VC Fund
3 China Seed, Series A, Series B Manufacturing, Artificial Intelligence, Sensor $1.5M–$16M
Jiadao Capital
VC Fund
3 China Angel, Seed, Series A Biotechnology, Medical, Manufacturing $1.4M–$49M
Angel Bridge
VC Fund
3 Japan Series A, Seed, Series B Information Technology, Software, Consulting $792k–$47M
Nippon Venture Capital
VC Fund
3 Japan, United States, Indonesia Series A, Series B Software, Health Care, Information Technology $1.5M–$269M
EDBI
VC Fund
3 United States, Singapore, India Series C, Series B, Series D Biotechnology, Software, Health Care $12M–$400M
Oriental Fortune Capital
VC Fund
3 China, United States Series A, Series B, Seed Software, Manufacturing, Information Technology $1.4M–$100M
Matrix Partners China
VC Fund
3 China, United States, Singapore Series A, Series B, Seed Health Care, Software, Artificial Intelligence $2.8M–$137M
ASBV
VC Fund
3 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $425k–$34M
Senshu Ikeda Capital
VC Fund
3 Japan Series A, Seed Manufacturing, Software, Internet $1M–$71M
Tianjin Venture Capital
VC Fund
3 China, United States Seed, Series A Manufacturing, Information Technology, Biotechnology $202k–$31M
CD Capital
VC Fund
3 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Access all 50 investors in Asia Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 10 investments in Asia Life Science startups, 7 in the past 12 months

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 81
  • Round size: Seed $2.5M–$14M; Series A $2.8M–$28M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 6 investments in Asia Life Science startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 898
  • Round size: Series A $5M–$67M; Series B $9.4M–$100M; Series C $15M–$134M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Guangjing Energy — Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.
  • Talaris Therapeutics — Talaris seeks to help kidney transplant recipients and patients suffering from severe auto-immune diseases to live healthy lives free from chronic immunosuppression
  • Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 6 investments in Asia Life Science startups

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 576
  • Round size: Series A $1.2M–$74M; Series B $4.3M–$198M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
  • WARPSPACE — ARPSPACE is a space startup originating from the University of Tsukuba, has been launching and working on a satellite development project at the University of Tsukuba for five years until the company was established.
  • Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 6 investments in Asia Life Science startups

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 584
  • Round size: Series A $1.5M–$106M; Series B $3.1M–$184M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • LQUOM — QWAVE offers cryptography communication technology.
  • Atom — Atom is a humanoid robot built platform. Its bipedal, dual-armed robots are designed not just as industrial tools but as collaborators that expand human capability. By combining advanced Physical AI—environmental perception, judgment, and action planning—with robust robotic hardware, Atom is creating adaptive agents capable of working acrossdiverse settings to augment or, where appropriate, replace human labor. The company positions these robots as a next step in societal evolution: a new class of machines that learn and behave in human-like ways to advance productivity, safety, and quality of life.
  • Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Show all investments...

Linear Capital
VC Fund · Shanghai, Shanghai, China · 6 investments in Asia Life Science startups, 25 in the past 12 months

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Manufacturing
  • Stage:Seed, Angel, Series A
  • Geography: China, Singapore, Switzerland

Investor stats

  • Total investments: 93
  • Round size: Seed $1.4M–$122M; Angel $1.4M–$122M; Series A $5.7M–$29M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • Zhengqi Future — Zhengqi Future focuses on developing embody intelligent robots for a 3km radius living environment.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
Show all investments...

IT-Farm
VC Fund · Tokyo, Tokyo, Japan · 6 investments in Asia Life Science startups

IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United States, Japan, Germany

Investor stats

  • Total investments: 126
  • Round size: Seed $1.5M–$7.5M; Series A $1.6M–$16M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
  • POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
  • Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 6 investments in Asia Life Science startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$157M; Series B $15M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 5 investments in Asia Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 195
  • Round size: Seed $2.5M–$35M; Series A $2.8M–$64M; Series B $2.8M–$100M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
  • TXP Medical — TXP Medical build a next-generation medical system through acute care.
  • Startbahn — Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We alsorun joint projects with other companies.
Show all investments...

HSG
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 5 investments in Asia Life Science startups

HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series B, Series A, Seed
  • Geography: China, United States, Australia

Investor stats

  • Total investments: 608
  • Round size: Seed $2M–$60M; Series A $10M–$100M; Series B $14M–$282M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/7a5aSCUfnr https://t.co/x14hb3jO7O
  • Full Truck Alliance — Full Truck Alliance is a platform that connects shippers with truckers to facilitate shipments across distance ranges and cargo weights. its revenues principally from shippers' and truckers' use of its platforms in connection with freight matching services.
  • Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 5 investments in Asia Life Science startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 77
  • Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Yatsen Holding — Yasten provides high-quality fashion makeup products.
  • kaye technology — Kaye Technology is a company that provides automation upgrade solutions for beverage equipment.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
DG Daiwa Ventures
VC Fund · Marunouchi, Tokyo, Japan · 5 investments in Asia Life Science startups, 15 in the past 12 months

DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 85
  • Round size: Seed $679k–$7M; Series A $3M–$103M; Series B $6.5M–$122M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Listie — Listie is an industrial engineering company that develops, supplies, and maintains lithium separation equipment and membranes. It is an important infrastructure resource that supports modern life, including electric vehicles, smartphones, and renewable energy storage.
  • Dioseve — Dioseve is providing novel possibilities for all life.
  • BEAM Technologies — BEAM Technologies, focuses on developing optical semiconductor devices using special light to offer clean solutions to ecosystem-related problems.
Show all investments...

Lenovo Capital and Incubator Group (LCIG)
VC Fund · Beijing, Beijing, China · 5 investments in Asia Life Science startups

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Software
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 302
  • Round size: Seed $1.5M–$29M; Series A $1.5M–$74M; Series B $8M–$150M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $500M in 2016

Portfolio highlights

  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
  • Shenzhen Urban Transport planning Center — Shenzhen Urban Transport planning Center provides traffic information engineering and technical services in China.
Show all investments...

SBI Investment
VC Fund · Minato, Chiba, Japan · 5 investments in Asia Life Science startups

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series B, Series A
  • Geography: Japan, South Korea, United States

Investor stats

  • Total investments: 386
  • Round size: Series A $2.3M–$142M; Series B $5.3M–$142M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2020

Portfolio highlights

  • LQUOM — QWAVE offers cryptography communication technology.
  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
  • Direava — Direava is a medical device company that manufactures, sells, leases, and maintains medical equipments along with consulting services.
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 4 investments in Asia Life Science startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 89
  • Round size: Seed $1.8M–$43M; Series A $3M–$49M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
  • LQUOM — QWAVE offers cryptography communication technology.
  • Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 4 investments in Asia Life Science startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 142
  • Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$50M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
  • Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Life Science startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 82
  • Round size: Series A $1.4M–$36M; Series B $14M–$100M; Series C $14M–$74M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
  • Heluo New Image — Heluo New Image is a cell treatment platform developer that focuses on iPSC directed differentiation, gene editing, large-scale cell product production, and cell therapy technology development.
  • Xgene Pharmaceutical — Xgene Pharmaceutical is a pharmaceutical company.
Show all investments...

Vinno Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Life Science startups

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 38
  • Round size: Series A $1.4M–$70M; Series B $11M–$139M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • HeYi New Energy — HeYi New Energy focuses on high-energy-density battery products, with its core offerings centered on advanced micro batteries for wearable devices, delivering efficient, long-lasting power solutions designed to support compact electronics and next-generation smart technologies.
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
  • Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Show all investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Asia Life Science startups

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, Ethiopia

Investor stats

  • Total investments: 264
  • Round size: Seed $565k–$43M; Series A $2M–$71M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Welyco — Welyco is an information technology company.We operate smart restaurant "solto". Utilize IT to realize efficient and diverse restaurant management.
  • Toranotec — TORANOTEC CORPORATION aims to create a world where investment is familiar to everyone by realizing "from consumption to investment" through the services of asset management subsidiaries , utilizing advanced technology.
  • Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups, 9 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 143
  • Round size: Angel $425k–$15M; Series A $1.4M–$67M; Series B $3.5M–$147M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • SeaArt — SeaArt AI is an all-in-one AI creativity community for art, videos, audio, and AI chats, where creators collaborate, spark inspiration, and grow together.
  • GigaAI — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Falcon Technology — Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications.
Show all investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 225
  • Round size: Seed $1.9M–$28M; Series A $1.4M–$43M; Series B $8M–$145M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Kebotix — Kebotix is a high-tech materials discovery and production company. It is to reinvent the materials industry and enable a new age of discovery of new materials using AI, machine learning, and robotics. Kebotix is just coming out of stealth mode. It was founded in 2017 and is headquartered in Cambridge, Massachusetts.
  • Numerion Labs — Our AI superplatform explores chemical space for novel molecules, enhancing drug discovery using machine learning to uncover unseen potential.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Miyako Capital
VC Fund · Kyoto, Kyoto, Japan · 4 investments in Asia Life Science startups

Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 52
  • Round size: Seed $750k–$43M; Series A $4.8M–$50M; Series B $3.7M–$354M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2019

Portfolio highlights

  • Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
  • Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
Show all investments...

UntroD Capital
VC Fund · Sumida, Tokyo, Japan · 4 investments in Asia Life Science startups, 14 in the past 12 months

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 138
  • Round size: Seed $772k–$28M; Series A $2.3M–$90M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
  • Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
  • IGrid Solutions — IGrid Solutions will promote “eDCM” to optimize power energy demand.
Show all investments...

JAFCO
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: Japan, United States, Israel

Investor stats

  • Total investments: 304
  • Round size: Series A $2.1M–$142M; Series B $6.4M–$184M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
  • Yokohama Vanilla — Yokohama Vanilla is a Company which operates Yokohama-based gift sweets brand.
Show all investments...

CITIC Capital Holdings
VC Fund · Central, Hong Kong Island, Hong Kong · 3 investments in Asia Life Science startups

CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 103
  • Round size: Series A $3.2M–$230M; Series B $2.8M–$50M; Series C $10M–$220M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $2.8B in 2018

Portfolio highlights

  • NEON — Discover a global experience entertainment company specialising in unique, immersive and large-scale experiences held all around the world, all year round.
  • Genta Kyushu Bio — Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies.
  • Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Show all investments...

Longpan Investment
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups, 14 in the past 12 months

Longpan Investment is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 43
  • Round size: Seed $14M–$60M; Series A $14M–$30M; Series B $14M–$37M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Jingling Zhikang — Jingling Zhikang is technology company specializing in the intersection of medical rehabilitation, robotics, and embodied artificial intelligence. The company focuses on developing intelligent rehabilitation bionic hands and upper-limb prosthetics.
  • Hanyue New Materials — Hanyue Advanced Materials is a high-tech company that specializes in single-use biopharmaceutical solutions.
  • Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 3 investments in Asia Life Science startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 171
  • Round size: Seed $7.9M–$41M; Series A $3.8M–$47M; Series B $7.1M–$73M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Dami&Xiaomi — Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information.
  • CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

ULTIMA
VC Fund · Chengdu, Sichuan, China · 3 investments in Asia Life Science startups

ULTIMA is an investment management firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Fitness
  • Stage:Angel, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 5
  • Round size: Series A $1.6M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 13 in the past 12 months

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: Japan, United Kingdom

Investor stats

  • Total investments: 90
  • Round size: Seed $826k–$50M; Series A $2.2M–$64M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
  • Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

Entrepreneurship Relay Group
VC Fund · Yangpu, Hainan, China · 3 investments in Asia Life Science startups

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Enterprise
  • Stage:Series A, Angel
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Series A $222k–$30M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
  • Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Show all investments...

ANRI
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Show more...

Investment focus

  • Industry: Software, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Japan, United States, Indonesia

Investor stats

  • Total investments: 269
  • Round size: Seed $413k–$19M; Series A $2.3M–$41M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $102M in 2022

Portfolio highlights

  • Any Style — Any Style develops a messaging app from voice actors that regularly sends messages via subscription. It also engages in the planning and production of audio content and the VTuber production business.
  • Chaintope — Chaintope is specializes in blockchain technology with a focus for FinTech and non-FinTech sectors.
  • Smile Robotics — Smile Robotics provides Service Robots in Japan.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Legend Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 427
  • Round size: Series A $2.9M–$100M; Series B $12M–$115M; Series C $15M–$200M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/7a5aSCUfnr https://t.co/x14hb3jO7O
  • Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
  • Jinqirui Biology — Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Show all investments...

Haitang Fund
VC Fund · Nankai, Tianjin, China · 3 investments in Asia Life Science startups, 19 in the past 12 months

Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: China

Investor stats

  • Total investments: 49
  • Round size: Seed $7.9M–$15M; Series A $1.5M–$103M; Venture - Series Unknown $14M–$44M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Layerwave Bio — Layerwave Bio is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments.
  • Yuanli Semiconductor — Yuanli Semiconductor develops and supplies an innovative AI computing power infrastructure.
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 46
  • Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$187M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2015

Portfolio highlights

  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Show all investments...

Japan Science and Technology Agency
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 7 in the past 12 months

Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan.  It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Manufacturing
  • Stage:Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 54
  • Round size: Seed $1.7M–$50M; Series A $2.3M–$255M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
  • Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
  • Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Life Science startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 533
  • Round size: Series A $1.6M–$156M; Series B $14M–$142M; Series C $4.3M–$156M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Prosemi — Pusenmei is a precision micro-resistance current sensor developer company committed to delivering professional and diverse precision micro-resistance current detecting resistors and circuit protection solutions.
  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Waker Biology — Weike Bio is a gene therapy drug development company.
Show all investments...

ZSVC
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups, 18 in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, India

Investor stats

  • Total investments: 143
  • Round size: Seed $1.4M–$4M; Series A $1.4M–$21M; Series B $2.8M–$85M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Tpson — Tpson is a Smart Hardware company.
  • Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
  • HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 274
  • Round size: Seed $1.3M–$100M; Series A $4.3M–$67M; Series B $11M–$62M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

Mizuho Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 477
  • Round size: Series A $2M–$79M; Series B $2.1M–$269M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
  • bestat — bestat is a developer of platforms for 3D data creation, management, and utilization using AI and offers digital twins services.
  • FunPep — FunPep is an Industry-university collaboration bioventure company.
Show all investments...

MiraclePlus
VC Fund · Haidian, Beijing, China · 3 investments in Asia Life Science startups, 15 in the past 12 months

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Angel, Pre-Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 76
  • Lead/follow: no public data

Portfolio highlights

  • TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
  • Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Show all investments...

Inspiration Capital
VC Fund · 3 investments in Asia Life Science startups, 9 in the past 12 months

Inspiration Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Sensor
  • Stage:Seed, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 23
  • Round size: Seed $1.5M–$15M; Series A $16M–$16M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Youshu Quantum — Youshu Quantum is a deep-tech startup specializing in quantum computing software, middleware, and proprietary algorithms.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • Chipworld Optoelectronics — Shanghai Xinjie Guanghe Technology Co., Ltd. is a high-tech chip design enterprise specializing in the research, development, and engineering of all-optical interconnect platforms and silicon-based optical switching chips for artificial intelligence computing clusters.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Jiadao Capital
VC Fund · 3 investments in Asia Life Science startups, 9 in the past 12 months

Jiadao Capital is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Manufacturing
  • Stage:Angel, Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 22
  • Round size: Seed $2.2M–$15M; Angel $1.4M–$49M; Series A $15M–$15M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Rabbitpre — Rabbitpre is a big data-driven technology marketing company.
  • Lead Health — Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights.
  • Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Show all investments...

Angel Bridge
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 17 in the past 12 months

Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Consulting
  • Stage:Series A, Seed, Series B
  • Geography: Japan

Investor stats

  • Total investments: 73
  • Round size: Seed $792k–$28M; Series A $2.5M–$19M; Series B $6.5M–$47M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $152M in 2019

Portfolio highlights

  • Recerqa — Recerqa is a supply chain management SaaS that utilizes advanced development technology and AI to improve the purchasing, inventory, and sales management experiences.
  • Mign — Mign offers a generative AI-related SaaS solutions for the construction and real estate fields.
  • Henry — Henry develops and provides a cloud-based electronic medical record and receipt system for small and medium-sized hospitals.
Show all investments...

Nippon Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 14 in the past 12 months

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Series B
  • Geography: Japan, United States, Indonesia

Investor stats

  • Total investments: 172
  • Round size: Series A $1.5M–$74M; Series B $3.3M–$269M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $278M in 2023

Portfolio highlights

  • Space BD — Space BD aims to become a one-stop shop to respond to all issues related to industrialization of space, and alleviate the work of businesses that are developing new technologies.
  • KUZEN — KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

EDBI
VC Fund · Singapore, Central Region, Singapore · 3 investments in Asia Life Science startups

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, India

Investor stats

  • Total investments: 194
  • Round size: Series B $20M–$170M; Series C $12M–$275M; Series D $17M–$400M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Paxata — The DataRobot End-of-Life (EOL) policy helps manage product lifecycle phases in a way that is transparent and clear for customers who will seamlessly transition to a new product or service.
  • Rotimatic — Rotimatic uses IoT and AI technologies to measure ingredients, knead dough, roll it out, cook, and shape perfectly round flatbreads in sequence. The system supports consistency, portion control, and customizable ingredient mixtures, allowing users to tailor recipes to dietary preferences. Rotimatic’s product is designed to simplify the process ofpreparing flatbreads, reducing time and physical effort.At Zimplistic, our mission is to tackle real-world problems to improve the daily lives of people. This gave rise to Rotimatic, our flagship product. It is the world's first kitchen robot that makes fresh, healthy, homemade rotis with a touch of a button.About Rotimatic - Rotimatic is a roti-making appliance that uses artificial intelligence to make rotis (flatbreads) without the need for human supervision. It is a fully automatic robot that processes all the essential ingredients and produces hot and delicious rotis in under a minute.Rotimatic is a technology marvel, packed with some cutting-edge technology innovated by a talented group of health-conscious people. A complete game changer globally - it is compact, user-friendly, and makes preparing rotis a cakewalk. Since its launch in 2016, Rotimatic has disrupted the kitchen appliances segment by piquing the interest of many.By knocking the hassle out of healthy eating, and helping everyone eat fresh food made at home with handpicked ingredients, we believe that people will eat healthier and live better with Rotimatic. It's become a worldwide kitchen sensation with over 3 million rotis served in thousands of households until June 2017.Rotimatic is available for purchase in Singapore, US, UK, Canada, Australia, and New Zealand. Order now - https://rotimatic.com/order/
  • TriReme Medical — TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Life Science startups

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 278
  • Round size: Seed $2.9M–$100M; Series A $1.4M–$43M; Series B $8.5M–$100M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Awomo — Awomo, an AI technology service provider and focuses on the field of Physical AI, dedicated to building foundational models and intelligent systems for robots and the real world.
  • Youshu Quantum — Youshu Quantum is a deep-tech startup specializing in quantum computing software, middleware, and proprietary algorithms.
  • Lightwheel — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 498
  • Round size: Seed $2.8M–$98M; Series A $3M–$61M; Series B $10M–$137M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Camera360 — Camera360 is a professional but easy-to use App for photo editing and selfie retouching. Tag #camera360
  • Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Life Science startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 28
  • Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$34M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Senshu Ikeda Capital
VC Fund · Osaka, Osaka, Japan · 3 investments in Asia Life Science startups

Senshu Ikeda Capital offers financial consultancy services.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Internet
  • Stage:Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 66
  • Round size: Seed $1M–$61M; Series A $1.9M–$71M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $177M in 2019

Portfolio highlights

  • JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
  • Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
  • LEP — LEP develops plants that glow without electricity.
Show all investments...

Tianjin Venture Capital
VC Fund · Tianjin, Guangdong, China · 3 investments in Asia Life Science startups

Tianjin Venture Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: China, United States

Investor stats

  • Total investments: 106
  • Round size: Seed $413k–$15M; Series A $202k–$31M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
  • Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 73
  • Round size: Seed $1.4M–$15M; Series A $1.4M–$32M; Series B $7.1M–$34M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
  • Pipi Bear — Pipi Bear is a creator of living robots and health goods, with a focus on those that improve the lives of the elderly.
  • CORE Biomedicine — CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists